Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P W Collins

Showing results (101-110 of 151) with videos related to

Pageof 16
Sort By:
Agents and Actions|September 1, 1991
Effects of the prostaglandin analogue misoprostol on inflammatory mediator release by human monocytesD L Widomski, R E Walsh, D A Baron, et al.
Journal of Thrombosis and Haemostasis : JTH|January 16, 2009
Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia AP W Collins, V S Blanchette, K Fischer, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 11, 2018
Intracranial haemorrhage in children with inherited bleeding disorders in the UK 2003-2015: A national cohort studyE A Chalmers, J Alamelu, P W Collins, et al.
Thrombosis and Haemostasis|November 1, 2001
Elective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated factor VII: plasma factor VII activity of 10 IU/ml is associated with an increased incidence of bleedingM P Smith, C A Ludlam, P W Collins, et al.
Journal of Thrombosis and Haemostasis : JTH|December 1, 2009
Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimensP W Collins, S Björkman, K Fischer, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 24, 2015
The epidemiology and outcomes of women with postpartum haemorrhage requiring massive transfusion with eight or more units of red cells: a national cross-sectional studyL Green, M Knight, F M Seeney, et al.
International Journal of Obstetric Anesthesia|May 17, 2021
The incidence, aetiology, and coagulation management of massive postpartum haemorrhage: a two-year national prospective cohort studyS F Bell, R E Collis, C Bailey, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 2, 2016
Association of peak factor VIII levels and area under the curve with bleeding in patients with haemophilia A on every third day pharmacokinetic-guided prophylaxisL A Valentino, S W Pipe, P W Collins, et al.
Journal of Thrombosis and Haemostasis : JTH|April 20, 2010
Comparative pharmacokinetics of plasma- and albumin-free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age-related differences and implications for dose tailoringS Björkman, V S Blanchette, K Fischer, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 17, 2004
The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' OrganizationM Laffan, S A Brown, P W Collins, et al.
Pageof 16

Showing results (101-110 of 151) with videos related to

Sort By:
Pageof 16
Agents and Actions|September 1, 1991
Effects of the prostaglandin analogue misoprostol on inflammatory mediator release by human monocytesD L Widomski, R E Walsh, D A Baron, et al.
Journal of Thrombosis and Haemostasis : JTH|January 16, 2009
Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia AP W Collins, V S Blanchette, K Fischer, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 11, 2018
Intracranial haemorrhage in children with inherited bleeding disorders in the UK 2003-2015: A national cohort studyE A Chalmers, J Alamelu, P W Collins, et al.
Thrombosis and Haemostasis|November 1, 2001
Elective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated factor VII: plasma factor VII activity of 10 IU/ml is associated with an increased incidence of bleedingM P Smith, C A Ludlam, P W Collins, et al.
Journal of Thrombosis and Haemostasis : JTH|December 1, 2009
Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimensP W Collins, S Björkman, K Fischer, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 24, 2015
The epidemiology and outcomes of women with postpartum haemorrhage requiring massive transfusion with eight or more units of red cells: a national cross-sectional studyL Green, M Knight, F M Seeney, et al.
International Journal of Obstetric Anesthesia|May 17, 2021
The incidence, aetiology, and coagulation management of massive postpartum haemorrhage: a two-year national prospective cohort studyS F Bell, R E Collis, C Bailey, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 2, 2016
Association of peak factor VIII levels and area under the curve with bleeding in patients with haemophilia A on every third day pharmacokinetic-guided prophylaxisL A Valentino, S W Pipe, P W Collins, et al.
Journal of Thrombosis and Haemostasis : JTH|April 20, 2010
Comparative pharmacokinetics of plasma- and albumin-free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age-related differences and implications for dose tailoringS Björkman, V S Blanchette, K Fischer, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 17, 2004
The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' OrganizationM Laffan, S A Brown, P W Collins, et al.
Pageof 16